Provider Review / Checked July 2026 · Updated 2026-07-17

MadeMed ED Review: The 3-in-1 Troche, Subscription Terms, and Evidence

MadeMed’s formula is easy to describe and difficult to evaluate as a unit: one established PDE5 inhibitor plus two ingredients used to target desire and intimacy, with no FDA approval of the finished three-drug troche.

Research review by the EdClinic Editorial Team · our research standards · not a substitute for professional medical advice
Bottom line: MadeMed’s public sexual-health page currently lists tadalafil + PT-141 + oxytocin and advertises treatment “from $49/mo.” Older affiliate materials supplied to EdClinic listed $119 monthly or $89 per refill on a quarterly plan. Because those numbers do not match, the live checkout terms must control.

In this guide

  1. The short verdict
  2. What is in the MadeMed troche
  3. What the pricing signals mean
  4. Telehealth and fulfillment questions
  5. Evidence and safety assessment
  6. What MadeMed does well and where it is weak
  7. Who it fits
  8. Frequently asked questions

The short verdict

MadeMed is designed for someone specifically interested in a compounded multi-mechanism troche rather than a conventional sildenafil or tadalafil tablet. It offers a clean brand, a simple product proposition, and a fully online path.

The trade-off is evidence and pricing clarity. Tadalafil has a large approved ED evidence base, while PT-141 use in men is off-label and oxytocin’s added clinical value is uncertain. The finished three-ingredient troche has not been FDA-approved.

The price discrepancy between the public “from $49” claim and older program materials should be resolved at checkout before EdClinic publishes a fixed monthly number.

What is in the MadeMed troche

The public site identifies tadalafil, PT-141, and oxytocin. Tadalafil supports erectile blood flow through PDE5 inhibition. PT-141, or bremelanotide, acts centrally through melanocortin receptors and is marketed around desire or arousal. Oxytocin is used for a proposed intimacy or bonding dimension.

That gives the product a neat story: performance, desire, and connection. The evidence is not equally strong across those three claims. FDA-approved tadalafil is established for ED, but the approved bremelanotide product is not indicated in men, and human oxytocin studies have not demonstrated a predictable improvement in male sexual behavior.

The exact strength of each ingredient should appear before purchase or on the prescription plan. A formula name without ingredient amounts is not enough for a medication review.

What the pricing signals mean

MadeMed’s public sexual-health and treatment pages currently say the 3-in-1 troche starts at $49 per month. The affiliate program brief supplied for this project listed $119 per month or $89 per refill on a quarterly plan. Several explanations are possible: a new promotion, different quantity, introductory pricing, commitment discount, or outdated affiliate data.

Do not average the numbers or choose the one that converts best. Record the quantity, refill interval, first charge, later charge, shipping, consultation, and commitment term shown at checkout. A “from” price may reflect the longest plan or smallest effective monthly allocation.

The fairest comparison is cost per prescribed dose and total committed spend, not a headline monthly figure.

Telehealth and fulfillment questions

MadeMed presents itself as a telehealth treatment platform and displays LegitScript certification on its site. The process likely includes intake, clinician review, prescription when appropriate, compounding-pharmacy fulfillment, and recurring delivery, but the public pages visible in our review provide limited detail on the specific pharmacy and state availability for this formula.

Ask whether the medical review is asynchronous, video-based, or state-dependent; which professional entity provides care; and which pharmacy compounds the troche. LegitScript certification is a useful platform signal but does not mean LegitScript or FDA approved the medication’s efficacy.

Confirm what happens if the clinician does not approve treatment and whether any consultation fee remains.

Also ask for the refill clock in calendar days rather than accepting the word “monthly.” A plan billed every four weeks creates thirteen charges in a year, while a true monthly plan creates twelve. The cancellation cutoff matters just as much: a customer should know whether stopping the next shipment requires action before a clinician review, before pharmacy processing, or before the card is charged.

Evidence and safety assessment

Tadalafil carries nitrate, blood-pressure, vision, hearing, and priapism warnings. PT-141’s approved labeling describes transient blood-pressure increases, nausea, headache, flushing, injection reactions, and hyperpigmentation; a troche route does not automatically inherit the approved product’s dose or evidence. Oxytocin adds less-defined benefit and safety data in this context.

A three-ingredient formula also makes troubleshooting harder. If the user develops nausea, headache, dizziness, flushing, or no benefit, it may be unclear which component or dose needs adjustment.

MadeMed should be judged on whether its clinician can explain why all three ingredients are appropriate for the specific patient, not simply on whether the formula sounds comprehensive.

What MadeMed does well and where it is weak

StrengthLimitation
Simple, memorable three-ingredient propositionFinished combination lacks FDA approval and direct comparative trials
Online process and discreet delivery positioningPublic ingredient strengths and pharmacy details are not prominent
May interest men seeking more than a blood-flow-only approachPT-141 male use and oxytocin benefit require careful qualification
Public starting price is attractiveCurrent public and affiliate price signals conflict

Who it fits

MadeMed may fit a patient who has already discussed standard options, understands compounding, specifically wants a troche, and accepts the uncertainty around the added ingredients. It is less appropriate as an impulse purchase based on “desire and intimacy” marketing.

First-time treatment shoppers should compare it with a single-ingredient approved generic. If tadalafil alone has never been tried correctly, starting with three ingredients sacrifices useful diagnostic clarity.

Patients taking nitrates or riociguat, people for whom sexual activity is medically inadvisable, and anyone with concerning cardiovascular status need direct medical evaluation rather than a marketing-page comparison.

Advertising disclosure: EdClinic.co may earn a commission when you visit a provider through a paid link. This does not change the price you pay or the standards used in this review.
Compounded 3-in-1 troche

MadeMed

MadeMed currently promotes a tadalafil + PT-141 + oxytocin troche. Its public site says “from $49/mo,” while older affiliate materials list different monthly and quarterly figures, so verify the full checkout total and refill cadence.

Check MadeMed

Pricing, eligibility, prescribing, formula, and availability can change. The provider—not EdClinic—determines whether treatment is appropriate.

Frequently asked questions

Is MadeMed’s 3-in-1 troche FDA-approved?

No. Tadalafil is an FDA-approved drug, and bremelanotide has an approved product for a different population, but the finished tadalafil + PT-141 + oxytocin troche is compounded and not FDA-approved.

What does MadeMed cost?

The public site says from $49 per month. Older affiliate materials listed $119 monthly or $89 per refill on a quarterly arrangement. Verify the exact live quantity and total commitment.

Is PT-141 approved for men?

No. Vyleesi’s label says it is not indicated in men. A clinician may prescribe bremelanotide off-label when appropriate.

Does oxytocin make the formula better?

That has not been established in large trials of the exact formula. Its biological rationale is stronger than the clinical proof of added benefit.

Build a verification record before the first dose

Save the product page, checkout summary, prescription instructions, pharmacy label, and cancellation terms as a single record. Telehealth pages change quickly, and a later support conversation is easier when the exact formula, strength, count, charge, and renewal date are documented. A screenshot is especially useful when a provider uses several landing pages with different starting prices.

At the clinical level, write down every prescription, over-the-counter medication, supplement, nitrate or “poppers” exposure, cardiovascular diagnosis, blood-pressure issue, and prior ED treatment. Include what happened with earlier medication: dose, timing, food, alcohol, stimulation, benefit, and side effects. That history is more useful than saying a product “did not work.”

After treatment begins, record benefit and adverse effects without repeatedly testing a severe reaction. Contact the prescriber when the formula is ineffective, produces persistent symptoms, or creates uncertainty about another medication. Use emergency care for chest pain, fainting, sudden vision or hearing change, or an erection lasting more than four hours.

Sources and review basis

  1. MadeMed sexual health — official site Accessed July 17, 2026.
  2. MadeMed treatments — official site Accessed July 17, 2026.
  3. VYLEESI (bremelanotide) prescribing information — DailyMed Accessed July 17, 2026.
  4. Oxytocin, erectile function and sexual behavior: review — PubMed Accessed July 17, 2026.
  5. CIALIS (tadalafil) prescribing information — DailyMed Accessed July 17, 2026.
  6. Understanding the Risks of Compounded Drugs — FDA Accessed July 17, 2026.

Provider details and prices were checked against public pages on the date shown. A checkout screen, prescription decision, or pharmacy label can differ. Medical claims are summarized from labeling and research and are not personal medical advice.

Advertising and medical disclosure: EdClinic.co may earn a commission from paid provider links. Editorial conclusions are not purchased. Nothing on this page is medical advice, and no prescription is guaranteed. Seek emergency care for chest pain, fainting, sudden vision or hearing loss, or an erection lasting more than four hours.